Shorts
0:32
Stop Double Cleansing? A Dermatologist Explains
3 days ago
by
Chantel Hillestad, RN, MSN, DCNP, FNP-C,
0:15
HS is a Marathon, Not a Sprint
5 days ago
by
Martina Porter, MD
0:40
Why I love Dermatology: A Touching Piece of Advice
5 days ago
by
Victoria Garcia-Albea, NP
0:22
Advocating for Pediatric Patients
6 days ago
by
Eileen Cheever, MPAS, PA-C
0:42
Nursing Owns the Skin: Why Your Nurse's Input Matters
10 days ago
by
Kimberly Madison, DNP,
0:25
The Financial Skill Missing in Medicine
11 days ago
by
Justin Love, PA-C
0:47
Saving Time In The Clinic With AI
12 days ago
by
Kimberly Madison, DNP,
0:18
Is 'Natural' Skincare Actually Better?
13 days ago
by
Eileen Cheever, MPAS, PA-C
0:28
Stop Blaming Food for Acne: A Dermatologist Explains
14 days ago
by
Lisa Weiss, MMSc, PA-C
0:22
The #1 Thing Every Medical Professional Needs
16 days ago
by
Justin Love, PA-C
Podcasts
Continuing Medical Education
All News
Advertisement
An MCC case illustrates how travel distance and limited oncology access can influence treatment decisions and adherence in rural patients.
This review of the latest dermatological studies includes insights on JAKs in severe HS, reactive cutaneous capillary endothelial proliferation in esophageal SCC, PN treatment preferences, and more.
Aaron Farberg, MD, discusses Isoclear’s 3-phase approach to acne treatment, from active breakouts to long-term skin maintenance.
See how precision biologics—dupilumab, IL-13/IL-31 blockers, JAK inhibitors, and omalizumab—change treatment for atopic dermatitis and chronic spontaneous urticaria.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
HS microbiome studies fuel probiotic hype, but a new review finds evidence too thin for routine use and highlights key research gaps.
Stay ahead with a weekly roundup of the biggest practice management, AI, policy, business, and professional development updates in dermatology.
This review of the latest dermatological studies includes insights on fibromyalgia in rosacea patients, isotretinoin use and suicidality in adolescents, patient-centered teledermatology, and more.
Your Name Is on the Claim: Billing Compliance, Federal Enforcement, and Why the Provider Always Pays
In this edition of The Practice Playbook, learn incident-to rules, Mohs coding limits, NPI liability, and how audits and whistleblowers trigger FCA cases.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
Advertisement
Our July issue tackles melanoma surgery challenges, melasma in skin of color, new bemotrizinol sunscreen, atopic dermatitis breakthroughs, and billing insights from Whitney Hovenic, MD, Joseph Gatti, DMSc, Rivkah Epstein, PA-C, and more.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
In this episode, Renata Block, DMSCc, MMS, PA-C, discusses the new ICD-10 code for topical steroid withdrawal with Kelly Barta, the president and executive director of the International Topical Steroid Awareness Network.
Survey highlights APP autonomy, prescribing confidence, and treatment priorities in atopic dermatitis care
This review of the latest dermatological studies includes insights on the burden of flooding, finasteride versus dutasteride in AGA, myocardial dysfunction in psoriasis patients, and more.
Stay ahead with a weekly roundup of the biggest practice management, AI, policy, business, and professional development updates in dermatology.
A new commentary argues primary or acute care experience should be a prerequisite for clinicians entering aesthetic medicine to improve patient safety and clinical decision-making.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
New York has extended independent practice authority for qualified nurse practitioners through July 1, 2030, preserving the current framework and collaboration requirements.
Hormonal shifts shape psoriasis and atopic dermatitis through puberty, pregnancy, postpartum, and menopause, guiding safer treatment choices and protecting pregnancy outcomes.
This review of the latest dermatological studies includes insights on gut dysbiosis in inflammatory conditions, air pollution and vitiligo risk, emollient use in AD patients, and more.
The FDA accepted an sNDA for roflumilast cream 0.05% in infants, potentially expanding steroid-free treatment options for atopic dermatitis.
Genetic MR links gut microbiome shifts to eczema, dermatitis, rosacea and more, spotlighting cytokines like IL‑10, IL‑18 and IL‑6 as therapeutic targets.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
This review of the latest dermatological studies includes insights on granulomatous dermatoses during dupilumab therapy, SAAD-41 validation in alopecia, updated vitiligo trends, and more.
This review of the latest dermatological studies includes insights into vitiligo, including emerging surgical techniques, the impact of social media, camouflage agents, and more.
Career decisions in dermatology are too often driven by emotion rather than data, according to a new practice management column examining common pitfalls in contract evaluation and compensation negotiations.
Two clinic cases illustrate why dermatologic providers must apply broad general medicine training in every encounter.
The 3-phase Isoclear regimen pairs topical isotretinoin with clindamycin, tranexamic acid, niacinamide, and copper peptide based on treatment stage.
In the Chair puts you in the hot spot, challenging you to navigate complex, real-world cases.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
This review of the latest dermatological studies includes insights on a mobile AI platform for skin disease prescreening, COVID-19 outcomes in PsO patients on biologics, i-PRF) and laser therapy for facial rejuvenation, and more.
In the Chair puts you in the hot spot, challenging you to navigate complex, real-world cases.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
This review of the latest dermatological studies includes insights on PeakPASI in psoriasis severity, the future of digital derm lectures, negative pressure wound therapy, and more.
Turn Therapeutics is preparing to request an FDA meeting to discuss regulatory strategy and potential pathways toward market following successful Phase 2 completion.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.
In the Chair puts you in the hot spot, challenging you to navigate complex, real-world cases.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
Employment contracts can have enormous financial and career consequences, yet many clinicians review them too casually before signing.
This review of the latest dermatological studies includes insights on methylsulfonylmethane in dermatology, the use of ultrasound in cutaneous mastocytoma, AI-augmented morphometric reporting for aesthetic treatments, and more.
Clinical outcomes improved in both switch directions following treatment modification, with substantial reductions in PASI and EASI scores.
Evidence and experience together reinforce that extended leave can restore psychological well-being and professional sustainability.
Strong clinical observation and knowledge of disease variants are essential when advanced diagnostics are unavailable.
This review of the latest dermatological studies includes insights on familial HS comorbidities, localized HA acne patch therapy, profiles of dyshidrotic eczema patients, and more.
Resource-poor environments exist not only globally but also in everyday settings like nursing homes, prisons, foster care, and low-income households.
Researchers reported that patients with more extensive HS disease involvement experienced significantly greater financial strain.
In the Chair puts you in the hot spot, challenging you to navigate complex, real-world cases.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
This review of the latest dermatological studies includes insights on cross-linked HA for neck wrinkles, dupilumab for eczema molluscatum, 10 ms pulsed dye laser for rosacea, and more.
Listening to favorite music or white noise during cosmetic botulinum toxin injections eases pain and stress, especially for first-time patients, with simple, low-cost comfort benefits.
In the Chair puts you in the hot spot, challenging you to navigate complex, real-world cases.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
In this episode, Renata Block, DMSc, MMS, PA-C, and Zachary Rubin, MD, discuss the overlapping worlds of allergy and dermatology—and how better cross-specialty understanding can dramatically improve patient outcomes.
This review of the latest dermatological studies includes insights on social media and DTC pediatric alopecia treatments, BTX-A and Profhilo combination therapy, diagnostic barriers in dermatomyositis, and more.
About one-quarter of acne-related genetic variants also contribute to IBD risk.
In the Chair puts you in the hot spot, challenging you to navigate complex, real-world cases.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
In the pivotal trials, dupilumab significantly reduced itch severity and urticaria activity at week 24 and increased rates of well-controlled disease and complete response compared with placebo.
This review of the latest dermatological studies includes insights on Vitamin B12's connection to hyperpigmentation, treatment modalities for female pattern hair loss, 0.5% timolol maleate eye drops for rosacea, and more.
A new survey reveals the significant disconnect between dermocosmetic labeling and clinical reality. Explore more and vote in today's poll.
In the Chair puts you in the hot spot, challenging you to navigate complex, real-world cases.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
Affecting up to 25% of children worldwide, pediatric AD carries a significant quality of life burden that extends to caregivers.
The biologic is the first of its kind approved for young children with antihistamine-refractory CSU, expanding an existing indication that previously covered adults and adolescents.
This review of the latest dermatological studies includes insights on minoxidil in onychodystrophy, teleheath outcomes in HS patients, pediatric AD referrals, and more.
AI-analyzed EHRs show a surging burden of hidradenitis suppurativa, chronic urticaria, psoriasis, and eczema, with major comorbidities, costly care, and low biologic use.
In the Chair puts you in the hot spot, challenging you to navigate complex, real-world cases.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
Emerging acne therapies like narrow-spectrum antibiotics, hormonal agents, and immunomodulators are promising, more personalized alternatives to isotretinoin, according to new research.
Patients who are needle-averse may soon have effective non-injectable options with biologic-like results.
Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.
Offers must pair strong compensation with operational and cultural support to succeed.
Successful negotiation integrates compensation, productivity, procedural access, and autonomy to create a sustainable, well-valued clinical role.
Renata Block, DMSc, MMS, PA-C, and Jamie Restivo, MPAS, PA-C, explore how hypochlorous acid sprays and sodium hypochlorite washes simplify AD adjunct care, improving adherence, antimicrobial control, and symptom relief.
Clinician contract negotiation is often treated as administrative, but it directly affects pay, autonomy, workflow, and career trajectory.
Omar Noor, MD, FAAD, discusses strategies to improve psoriasis care for patients facing adherence challenges related to lifestyle or cognitive barriers.
Trainees identified legal, ethical, and reliability concerns as key barriers to integrating AI into dermatology practice.
Women often present with sudden skin, hair, and vascular changes that may signal perimenopause rather than normal aging.
Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, reviewed clinical trial and long-term data supporting biologic therapies for HS, emphasizing individualized patient selection and timing of intervention.
New top-line results from the BE BOLD trial provide dermatology clinicians with comparative data on 2 biologic therapies targeting different inflammatory pathways in psoriatic arthritis (PsA).
Jessica DeLuise, PA-C, MHS, CCMS, joins Derm Dispatch to discuss how nutrition and lifestyle intersect with inflammatory skin disease across clinical settings.
Douglas DiRuggiero, DMSc, MHS, PA-C, reviewed clinical cases highlighting the distinct roles of topical ruxolitinib, tapinarof, and roflumilast in managing itch, inflammation, and long-term disease control in atopic dermatitis.
Douglas DiRuggiero, DMSc, MHS, PA-C, emphasized that relying solely on body surface area underestimates psoriasis burden, particularly for patients with disease in high-impact or special areas.
Real-world data show IL-17 biologics rapidly improve special-site psoriasis and quality of life, as researchers identified predictors of PASI75/90 response.
Explore PDPA’s 2025 compensation survey, revealing dermatology PA salary trends, workload patterns, benefits insights, and job satisfaction across the state of Pennsylvania.
Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, highlighted that CHE is often mischaracterized and frequently involves overlapping subtypes.
Omar Noor, MD, shares pearls on type 2 inflammation, including dupilumab insights for atopic dermatitis, prurigo nodularis, and CSU at Horizons in Advanced Practice.
Baker explains why competency-based autonomy and structured collaboration are essential in high-acuity medical dermatology.
Dermatology Times recently concluded its second annual Horizons in Advanced Practice meeting in Tampa, Florida, featuring nurse practitioners and physician assistants from across the country.
HS is frequently misdiagnosed for 7 to 10 years because its symptoms resemble conditions like inflamed epidermal cysts, nodulocystic acne, and furuncles.
In the latest Cutaneous Connection podcast episode, Renata Block, DMSc, MMS, PA-C, and patient advocate Suki Tipp discuss the clinical, emotional, and financial toll of delayed diagnosis of indolent systemic mastocytosis.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!
Advertisement
Advertisement
Trending on Dermatology Times
1
Social Media Mythbusters: Hydrocolloid Pimple Patches
2
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
3
Envudeucitinib Shows Durable Skin Clearance in Phase 3 Psoriasis Extension
4
Q&A: Aaron Farberg, MD, on Isoclear and a 3-Phase Approach to Acne Management
5